Nutrinia

Neonatal Gastrointestinal Treatment

Health Tech & Life Sciences
Non Active, May 2020 ceased to operate
Series D Bnei Brak, Israel Founded 2003
LinkedIn
Last updated 2026-06-18
Total raised
$44.1M
Last: 2016-08
Stage
Series D
Founded
2003
Headcount
4
HQ
Bnei Brak, Israel
Sector
Health Tech & Life Sciences

About

Nutrinia is a neonatology company developing pharmaceuticals to treat rare conditions of the gastrointestinal tract. The company's current products in development are oral formulations of insulin shown to enhance adaptation and rehabilitation of the gut in infants. Nutrinia's insulin formulation is a powder that can be mixed with saline or infant formula before use. It is composed of insulin with excipients already approved for infant consumption, making it a safe drug product for infants. The formulation is intended to target and treat local GI issues with no absorption or systemic exposure.

Funding history · 4 rounds · $44.1M total

Q&A

What is Nutrinia's primary focus?
Nutrinia is a neonatology company that develops pharmaceuticals to treat rare conditions of the gastrointestinal tract in infants.
What is Nutrinia's current product in development?
Nutrinia is developing oral formulations of insulin designed to enhance adaptation and rehabilitation of the gut in infants. This formulation is a powder that can be mixed with saline or infant formula.
When was Nutrinia founded?
Nutrinia was founded in August 2003.
What is Nutrinia's operational status?
Nutrinia is currently inactive, having ceased operations in May 2020.
How much funding has Nutrinia raised in total?
Nutrinia has raised a total of $44,100,000 USD across all funding rounds.
When was Nutrinia's last funding round and who were the investors?
Nutrinia's last funding round occurred in August 2016, with investors including H.I.G. BioHealth Partners and TPG Biotech.
Which investors participated in Nutrinia's December 2014 funding round?
In December 2014, Nutrinia received funding from investors such as OrbiMed and Pontifax.

Team · 1

Founder · Founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

oral-drugsgastroenterologypharmaceuticalsbabiesdoctorspatients
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

LinkedInlinkedin.com/company/11008136

Identifiers & details

Founded2003-8
Employees (exact)4
OfficesMorristown
Status reasonNon Active, May 2020 ceased to operate